ENG

ENG简体中文日本語한국어

  • Yuru ZUO

    Equity Partner / Beijing

  • Tel +86-10-5087-2996

    Email zuoyuru@zhonglun.com

  • Practices

    Litigation & Arbitration, Compliance & Investigation, IP Licensing & Enforcement

  • Industries

    Pharmaceuticals & Life Sciences

CV

Yuru ZUO

In the field of healthcare and life science, Ms. Zuo has provided dozens of pharmaceutical companies with retainer service, compliance consulting, compliance system construction, compliance training, etc. Ms. Zou’s client types cover pharmaceuticals production and sale enterprises, medical devices production and sale enterprises, health-care products production and sale enterprises, contract sales organizations, pharmaceuticals R&D enterprises, internet medical enterprises. Her services cover the entire life cycle of pharmaceuticals or medical devices，including R&D, clinical trials, human genetic related approval, product launch, product marketing and promotion, product liability disputes, etc..
Ms. Zuo is good at comprehensive compliance diagnosis and analysis of corporate business models, providing compliance suggestions and improvement plans, researching and judging corporate compliance weaknesses, helping companies build, improve, and perfect compliance systems, and assisting companies in dealing with external administrative and criminal investigation cases such as commercial bribery related cases to help enterprises survive the crisis smoothly.
In the field of dispute resolution, Ms. Zuo has participated in many litigation and arbitration cases involving multinational companies and listed companies. The types of cases involve equity transfer disputes, disputes over control rights, various types of contract disputes, product liability disputes, and anti-unfair competition disputes. She specializes in handling various types of commercial contract disputes involving pharmaceutical companies, including disputes relating to distribution agreements, promotion service agreements, R&D cooperation agreements, as well as product (pharmaceuticals or medical devices) liability disputes and SAE disputes during clinical trials.

Representative Matters

Medical Law Compliance

  • Provided compliance system building and compliance consulting services for a number of pharmaceutical manufacturers, medical device manufacturers, pharmaceutical R&D companies, promotion service providers, and internet medical companies, including but not limited to:

  • GlaxoSmithKline

  • Pfizer

  • Biogen

  • Sinovant Sciences

  • Terumo

  • Fosun Kite.


Responding to External Investigations

  • Assisted a multinational pharmaceutical company in responding to criminal investigation and litigation of commercial bribery.

  • Assisted a multinational pharmaceutical company in responding to administrative investigation of commercial bribery.

  • Assisted a multinational pharmaceutical company in responding to administrative investigation of false advertising.

  • Assisted several pharmaceutical companies in responding to administrative investigations of advertising.


Dispute Resolution

  • Represented the asset management plan of Cinda Securities to obtain the control of the listed company Zhongyida, and assisted the asset management plan in exercising shareholders rights, appointing new management, restoring governance of the listed company, clearing debts and liabilities, disposing of non-performing assets, promoting major asset restructuring and resuming listing.

  • Represented Jiangxi Province Tourism Group Co. and Contemporary Group in their fight for control of the listed company China United Travel(600358.SH), and assisted the client to restore the governance of the listed company, resume its operation and management, control its subsidiaries/branches, respond to its various company lawsuits.

  • Represented Bitmain, a leading global blockchain chip design and device manufacturer once valued at CNY 80 billion, in disputes over company control, providing comprehensive legal services involving corporate governance, asset protection, supply chain management, intellectual property and trade secret protection, taxation, etc.

  • Represented Nomura Securities in disputes over a large syndicated in the amount of $190 million.

  • Represented China United Travel in a dispute with Sun Guiyun over the transfer of equity interests.

  • Represented Dentsu Aegis Network in an arbitration case to rescind an equity sale and purchase contract.

Honors and Awards

For Individual

Next Generation Partners in Life Sciences and Healthcare, The Legal 500 Asia Pacific 2023 Edition

Rising Star in Healthcare, 2023 asialaw Profiles

Next Generation Partners in Life Sciences and Healthcare, The Legal 500 Asia Pacific 2022 Edition

Memberships & Affiliations

Member, the Talent Pool of International Lawyers of Beijing Lawyer Association

Related

  • Bar Admissions/Professional Qualifications

    PRC Bar

  • Education

    Master of Law (Intellectual Property Law Major), Peking University
    Bachelor of Biological Science, Peking University

  • Professional Experience

    Equity Partner, Non-equity Partner, Associate, Zhong Lun Law Firm
    Associate, Jun He Law Firm

  • Languages

    Chinese
    English